- Home
- OLED vs RVMD Comparison
OLED vs RVMD Comparison
Compare OLED & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLED
- RVMD
- Stock Information
- Founded
- OLED 1985
- RVMD 2014
- Country
- OLED United States
- RVMD United States
- Employees
- OLED N/A
- RVMD N/A
- Industry
- OLED Semiconductors
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OLED Technology
- RVMD Health Care
- Exchange
- OLED Nasdaq
- RVMD Nasdaq
- Market Cap
- OLED 7.4B
- RVMD 7.5B
- IPO Year
- OLED 1992
- RVMD 2020
- Fundamental
- Price
- OLED $156.00
- RVMD $38.11
- Analyst Decision
- OLED Strong Buy
- RVMD Strong Buy
- Analyst Count
- OLED 7
- RVMD 12
- Target Price
- OLED $190.43
- RVMD $68.67
- AVG Volume (30 Days)
- OLED 481.6K
- RVMD 3.3M
- Earning Date
- OLED 07-31-2025
- RVMD 08-06-2025
- Dividend Yield
- OLED 1.16%
- RVMD N/A
- EPS Growth
- OLED 4.58
- RVMD N/A
- EPS
- OLED 4.81
- RVMD N/A
- Revenue
- OLED $648,702,000.00
- RVMD N/A
- Revenue This Year
- OLED $5.75
- RVMD N/A
- Revenue Next Year
- OLED $10.76
- RVMD $241.39
- P/E Ratio
- OLED $32.33
- RVMD N/A
- Revenue Growth
- OLED 6.13
- RVMD N/A
- 52 Week Low
- OLED $103.70
- RVMD $29.17
- 52 Week High
- OLED $237.00
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- OLED 51.52
- RVMD 47.77
- Support Level
- OLED $155.77
- RVMD $36.37
- Resistance Level
- OLED $161.97
- RVMD $38.97
- Average True Range (ATR)
- OLED 4.03
- RVMD 1.50
- MACD
- OLED -0.47
- RVMD 0.02
- Stochastic Oscillator
- OLED 48.67
- RVMD 40.07
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.